In vitro susceptibility testing of dermatophytes: Comparison of disk diffusion and reference broth dilution methods

Diagnostic Microbiology and Infectious Disease

Volumn 48, Issue 4, 2004, Pages 259-264

  Karaca, Nuriye ^a   Koç, A Nedret ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Antifungals; Broth dilution; Dermatophytes; Disk diffusion

Indexed keywords

ANTIFUNGAL AGENT; BIFONAZOLE; CICLOPIROXOLAMINE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; OXICONAZOLE; SULCONAZOLE; TERBINAFINE;

ARTICLE; DERMATOPHYTE; DIFFUSION; DILUTION; FUNGAL STRAIN; FUNGUS GROWTH; GROWTH INHIBITION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DIFFUSION; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 1942456457     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2003.10.012     Document Type: Article

References (29)

1. Balfour J.A., Faulds D. Terbinafine a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs. 43:1992;259-284.
2. Barry A.L., Brown S.D. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J Clin Microbiol. 34:1996;2154-2157.
3. Espinel-Ingroff A., Barlett M., Bowden R., et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol. 35:1997;139-143.
4. Espinel-Ingroff A., Kerkering T.M., Goldson P.R., Shadomy S. Comparison study of broth macrodilution and microdilution antifungal susceptibility test. J Clin Microbiol. 29:1991;1089-1094.
5. Espinel-Ingroff A., Kish C.W., Kerkering T.M., et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol. 30:1992;3138-3145.
6. th ed:1999;1640-1652 ASM Press, Washington DC.
7. Fernández-Torres B., Carrillo A.J., Martin E., Del Palacio A., Moore M.K., Valverde A., Serrano M., Guarro J. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother. 45:2001;2524-2528.
8. Fernández-Torres B., Vázquez-Veiga H., Llova X., Pereiro M., Guarro J. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy. 46:2000;390-394.
9. Ghannoum M.A. Antifungal susceptibility testing of dermatophytes. Dermatol Online J. 7:2001;23C.
10. Ghannoum M.A., Rex J.H., Galgiani J.N. Susceptibility testing of fungi current status of correlation of in vitro data with clinical outcome. J Clin Microbiol. 34:1996;489-495.
11. Grant S.M., Clissold S.P. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs. 37:1989;310-344.
12. th ed:2000;2757-2768 Churchill Livingstone, Philadelphia.
13. Jessup C.J., Warner J., Isham N., Hasan I., Ghannoum M.A. Antifungal susceptibility testing of dermatophytes establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol. 38:2000;341-344.
14. th ed:1999;1275-1294 ASM Press, Washington DC.
15. Kibar F., Köksal F., Acar A., Akbaba M., Yoldascan E. Çesitli dermatofitlerin griseofulvin, flukonazol ve itrakonazol duyarliliklarinin in vitro arastirilmasi Mikrobiyol Bült. 35:2001;299-305.
16. Korting H.C., Rosenkrans S. In vitro susceptibility of dermatophytes from Munich to griseofulvin, miconazole and ketoconazole. Mycoses. 33:1989;136-139.
17. Korting H.C., Ollert M., Abeck D., Abeck D., et al. Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob Agents Chemother. 39:1995;1206-1208.
18. nd ed, (pp. 117-137). Washington DC
19. Macura A.B. In vitro susceptibility of dermatophtes to antifungal drugs a comparison of two methods. Int J Dermatol. 32:1993;533-536.
20. th ed:1996;176-211 Williams & Wilkins, Philadelphia.
21. Meis J., Petrou M., Bille J., Ellis D., Gibbs D., The Global Antifungal Surveillance Group. A. global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn Microbiol Infect Dis. 36:2000;215-223.
22. Mock M., Monod M., Baudraz-Rosselet F., Panizzon R.G. Tinea capitis dermatophytes susceptibility to antifungal drugs tested in vitro and in vivo. Dermatology. 197:1998;361-367.
23. Munro S. Disk diffusion susceptibility testing. Isenberg H.D. Clinical microbiolgy procedures handbook. 1:1992;5.1-5.2 ASM Press, Washington DC.
24. National Committee for Clinical Laboratory Standards. (1998). Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard. NCCLS document M38-P. Wayne, PA: NCCLS.
25. National Committee for Clinical Laboratory Standards. (1999). Performance standards for antimicrobial susceptibility testing. Ninth supplement to the M2-A6 M100-S9. Villanova, PA: NCCLS.
26. Norris H.A., Elewski B.E., Ghannoum M.A. Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol. 40:1999;S9-S13.
27. th ed.
28. Tümbay, E. (1983). Pratik tip mikolojisi, ss 69. Bilgehan Basimevi, İzmir.
29. Weitzman I., Summerbell R.C. The dermatophytes. Clin Microbiol Rev. 8:1995;240-259.